|
Gene expression associated with lymphovascular invasion and genomic risk in early-stage breast cancer. |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Cardiff Oncology; Pfizer; TG Therapeutics |
|
|
Speakers' Bureau - MJH Healthcare Holdings, LLC |
Research Funding - Agendia |
Travel, Accommodations, Expenses - Agendia |
|
|
|
Stock and Other Ownership Interests - Agendia |
Patents, Royalties, Other Intellectual Property - NXT Biologics |
|
|
|
Stock and Other Ownership Interests - Agendia |
|
|
No Relationships to Disclose |